1.Alternative Name:CD221
2.Target:IGF-1R
3.Source:Human IGF-1R was expressed from HEK293 with poly His at the C-terminal
4.Sequence:Glu31-Asn932
5.Protein structure:P08069His
6.Molecular Characterization:The protein has a calculated MW of 104kDa.The reducing (R) heterodimer protein migrates as 110-140 kDa due to glycosylation
7.Purity:SDS-PAGE>90%，SEC>90%
8.Reconstitution:sterile H2O
9.Endotoxin:<1EU/mg
10.Formulation:Lyophilized from 0.22 μm filtered solution in PBS, pH7.4.
11.SDS-PAGE

Determined by SDS-PAGE, the purity of the protein is greater than 90 %.

12.SEC-HPLC

Determined by SEC-HPLC, the purity of the protein is greater than 90%.

13.ELISA

When Anti-IGF1R[cixutumumab] is immobilized at 2μg/mL (100 μL/well), the concentration of Recombinant Human IGF-1R(31-932)/His Protein that produces 50% of the optimal binding response is approximately 0.2 ug/ml.

Note：For research use only .